The United States Court of Appeals for the Ninth Circuit has ruled that mRNA COVID-19 vaccines do not qualify as vaccines under traditional medical definitions.
Last week, Moderna announced that it has received approval from the Food and Drug Administration (FDA) for the development of an mRNA vaccine for respiratory syncytial virus (RSV).
A censored study published by the National Institutes of Health (NIH) found that mRNA vaccines potentially alter the DNA of recipients and their offspring.
A recent study analyzed the health data of 99 million patients across 8 countries, finding that numerous adverse side effects are linked to the COVID-19 vaccine.
